Literature DB >> 14689362

Safety and efficacy evaluation of pleconaril for treatment of the common cold.

Russell Fleischer, Katherine Laessig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14689362     DOI： 10.1086/379830

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.

Authors:  Jun Zuo; Steve Kye; Kevin K Quinn; Paige Cooper; Robert Damoiseaux; Paul Krogstad
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.

Authors:  Angus M MacLeod; Dale R Mitchell; Nicholas J Palmer; Hervé Van de Poël; Katja Conrath; Martin Andrews; Pieter Leyssen; Johan Neyts
Journal:  ACS Med Chem Lett       Date:  2013-05-08       Impact factor: 4.345

3.  Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.

Authors:  S L Binford; F Maldonado; M A Brothers; P T Weady; L S Zalman; J W Meador; D A Matthews; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.

Authors:  Ann C Palmenberg; David Spiro; Ryan Kuzmickas; Shiliang Wang; Appolinaire Djikeng; Jennifer A Rathe; Claire M Fraser-Liggett; Stephen B Liggett
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

Review 5.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 6.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 7.  Host immune responses to rhinovirus: mechanisms in asthma.

Authors:  John T Kelly; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

8.  Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3.

Authors:  Jae-Hyoung Song; Hwa-Jung Choi; Hyuk-Hwan Song; Eun-Hye Hong; Bo-Ra Lee; Sei-Ryang Oh; Kwangman Choi; Sang-Gu Yeo; Yong-Pyo Lee; Sungchan Cho; Hyun-Jeong Ko
Journal:  J Ginseng Res       Date:  2014-04-29       Impact factor: 6.060

9.  An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.

Authors:  Stephanie Traub; Alexandra Nikonova; Alan Carruthers; Rebecca Dunmore; Katherine A Vousden; Leila Gogsadze; Weidong Hao; Qing Zhu; Katie Bernard; Jie Zhu; Michael Dymond; Gary R McLean; Ross P Walton; Nicholas Glanville; Alison Humbles; Musa Khaitov; Ted Wells; Roland Kolbeck; Andrew J Leishman; Matthew A Sleeman; Nathan W Bartlett; Sebastian L Johnston
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

10.  Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a.

Authors:  Jaehyoung Song; Sang-Gu Yeo; Eun-Hye Hong; Bo-Ra Lee; Jin-Won Kim; Jeonghoon Kim; Hyeongun Jeong; Yongsoo Kwon; Hyunpyo Kim; Sangwon Lee; Jae-Hak Park; Hyun-Jeong Ko
Journal:  Biomol Ther (Seoul)       Date:  2014-01       Impact factor: 4.634
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.